Kingsley Makhubela attends "Redefining the Global Agenda" panel within TRT World Forum in Istanbul, Turkey on October 18, 2017. Elif Ozturk/Anadolu Agency/Getty Images Brand South Africa says its former CEO Kingsley Makhubela's claims of maladministration and abuse of power have been handed over to "relevant investigation authorities". City Press reported that Makhubela had compiled a report…
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 548c9128-2dce-4406-8a7a-028f2388
You don't have permission to access "http://www.cpsc.gov/Recalls/2026/DINBooonLUX-12-Inch-Full-Size-Mattresses-Recalled-Due-to-Risk-of-Serious-Injury-or-Death-from-Fire-Violates-Mandatory-Standard-for-Mattress-Flammability-Sold-on-Amazon-by-DINBooonLUX" on this server. Reference #18.f2a5dc17.1762092135.e7914f40 https://errors.edgesuite.net/18.f2a5dc17.1762092135.e7914f40
4 min read THERE'S BEEN A wave of new therapies for Alzheimer’s disease released over the last few years. But nothing would be as revolutionary as simply taking a pill to slow down cognitive decline. Better yet, the ideal medication would be a pill that could protect people with a genetic risk for Alzheimer's. That's